Deletion of cis-regulatory Element in FOXL2 Promoter in a Chinese Family of Type II Blepharophimosis-ptosis-epicanthus Inversus Syndrome with Polydactyly

被引:1
|
作者
Shen, Qin [1 ,2 ]
Zhao, Xiaojun [1 ,2 ]
Ji, Yongrong [1 ,2 ,3 ]
Chai, Peiwei [1 ,2 ,3 ]
机构
[1] Shanghai Jiao Tong Univ, Sch Med, Peoples Hosp 9, Dept Ophthalmol, Shanghai, Peoples R China
[2] Shanghai Key Lab Orbital Dis & Ocular Oncol, Shanghai, Peoples R China
[3] Shanghai Jiao Tong Univ, Peoples Hosp 9, Dept Ophthalmol, Sch Med, Shanghai 200025, Peoples R China
基金
上海市自然科学基金;
关键词
Blepharophimosis-ptosis-epicanthus inversus syndrome; FOXL2; mutations; polydactyly; FRASER-SYNDROME; MUTATION;
D O I
10.1097/SCS.0000000000009801
中图分类号
R61 [外科手术学];
学科分类号
摘要
Blepharophimosis-ptosis-epicanthus inversus syndrome (BPES) is a relatively uncommon autosomal-dominant genetic disorder, primarily attributed to mutations in the forkhead box L2 (FOXL2) gene. Albeit the involvement of protein-coding regions of FOXL2 has been observed in the majority of BPES cases, whether deficiencies in regulatory elements lead to the pathogenesis remains poorly understood. Herein, an autosomal-dominant BPES type II family was included. Peripheral venous blood has been collected, and genomic DNA has been extracted from leukocytes. A whole exome sequencing analysis has been performed and analyzed (Deposited in NODE database: OER422653). The promoter region of FOXL2 was amplified using polymerase chain reaction (PCR). The luciferase reporter assay was performed to identify the activity of this region. In this study, we present a Chinese family diagnosed with type II BPES, characterized by the presence of small palpebral fissures, ptosis, telecanthus, and epicanthus inversus. Notably, all male individuals within the family display polydactyly. A 225-bp deletion in the 556-bp 5 ' -upstream to transcription start site of FOXL2, decorated by multiple histone modifications, was identified in affected members of the family. This deletion significantly decreased FOXL2 promoter activity, as measured by the luciferase assay. Conclusively, a novel 255-bp-deletion of the FOXL2 promoter was identified in Chinese families with BPES. Our results expand the spectrum of known FOXL2 mutations and provide additional insight into the genotype-phenotype relationships of the BPES pathogenesis. In addition, this study indicates the important role of genetic screening of cis-regulatory elements in testing heritable diseases.
引用
收藏
页码:e52 / e56
页数:5
相关论文
共 50 条
  • [21] Identification of a novel FOXL2 mutation in a single family with both types of blepharophimosis-ptosis-epicanthus inversus syndrome
    Yang, Lin
    Li, Tuo
    Xing, Yiqiao
    MOLECULAR MEDICINE REPORTS, 2017, 16 (04) : 5529 - 5532
  • [22] Genomic Disruption of FOXL2 in Blepharophimosis-Ptosis-Epicanthus Inversus Syndrome Type 2: A Novel Deletion-Insertion Compound Mutation
    Niu, Bei-Bei
    Tang, Ning
    Xu, Qin
    Chai, Pei-Wei
    CHINESE MEDICAL JOURNAL, 2018, 131 (19) : 2380 - +
  • [23] Functional Analysis of a Novel FOXL2 Indel Mutation in Chinese Families with Blepharophimosis-Ptosis-Epicanthus Inversus Syndrome Type I
    Chai, Peiwei
    Li, Fang
    Fan, Jiayan
    Jia, Ruobin
    Zhang, He
    Fan, Xianqun
    INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2017, 13 (08): : 1019 - 1028
  • [24] Ovarian Reserve and ART Outcomes in Blepharophimosis-Ptosis-Epicanthus Inversus Syndrome Patients With FOXL2 Mutations
    Meng, Tingting
    Zhang, Wenzhe
    Zhang, Rongrong
    Li, Jie
    Gao, Yuan
    Qin, Yingying
    Jiao, Xue
    FRONTIERS IN ENDOCRINOLOGY, 2022, 13
  • [25] Heterozygous 17-bp deletion in the forkhead transcription factor gene, FOXL2, in a Japanese family with blepharophimosis-ptosis-epicanthus inversus syndrome
    Yamada, T
    Hayasaka, S
    Budu, MM
    Esa, T
    Hayasaka, Y
    Endo, M
    JOURNAL OF HUMAN GENETICS, 2001, 46 (12) : 733 - 736
  • [26] Novel FOXL2 variants in two Chinese families with blepharophimosis, ptosis, and epicanthus inversus syndrome
    Zhao, Mingyu
    Meng, Xiaolu
    Wang, Jiaqi
    Wang, Tailing
    FRONTIERS IN GENETICS, 2024, 15
  • [27] Novel FOXL2 mutations cause blepharophimosis-ptosis-epicanthus inversus syndrome with premature ovarian insufficiency
    Yang, Xiao-Wen
    He, Wen-Bin
    Gong, Fei
    Li, Wen
    Li, Xiu-Rong
    Zhong, Chang-Gao
    Lu, Guang-Xiu
    Lin, Ge
    Du, Juan
    Tan, Yue-Qiu
    MOLECULAR GENETICS & GENOMIC MEDICINE, 2018, 6 (02): : 261 - 267
  • [28] Heterozygous 17-bp deletion in the forkhead transcription factor gene, FOXL2, in a Japanese family with blepharophimosis-ptosis-epicanthus inversus syndrome
    T. Yamada
    S. Hayasaka
    M. Matsumoto
    T. Budu
    Y. Esa
    M. Hayasaka
    Journal of Human Genetics, 2001, 46 : 733 - 736
  • [29] FOXL2 mutations in Taiwanese patients with blepharophimosis, ptosis, epicanthus inversus syndrome
    Lin, Wei-De
    Chou, I-Ching
    Lee, Ni-Chung
    Wang, Chung-Hsing
    Hwu, Wuh-Liang
    Lin, Shuan-Pei
    Chao, Mei-Chyn
    Tsai, Yushin
    Tsai, Fuu-Jen
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2010, 48 (04) : 485 - 488
  • [30] Mutational analysis of forkhead transcriptional factor 2 (FOXL2) in Korean patients with blepharophimosis-ptosis-epicanthus inversus syndrome
    Cha, SC
    Jang, YS
    Lee, JH
    Kim, HK
    Kim, SC
    Kim, S
    Baek, SH
    Jung, WS
    Kim, JR
    CLINICAL GENETICS, 2003, 64 (06) : 485 - 490